Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Martín Garcia-Gonzalez, Russel J. Reiter

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

Original languageEnglish (US)
Pages (from-to)1162-1164
Number of pages3
JournalAmerican Journal of Cardiology
Volume97
Issue number8
DOIs
StatePublished - Apr 15 2006

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction'. Together they form a unique fingerprint.

Cite this